• Markets
    • icon
  • Companies
OSX · ASX

Osteopore Ltd. (ASX:OSX)

AU$0.05

 0.006 (13.636%)
ASX:Live
06/12/2023 04:10:05 PM
Hammer Bullish HALO Ords GROWTH AUS Big Candle (Realtime) All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OSX Overview

OSX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About OSX

Website

Osteopore Ltd.

Telephone

N/A

Address

Description

N/A

OSX Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-2.22%

1 month

-12%

YTD

-70.34%

1 year

-77.75%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

OSX Announcements

Latest Announcements

Date Announcements

31 October 23

Activities Update Qtr Ending September 2023 and Appendix 4C

×

Activities Update Qtr Ending September 2023 and Appendix 4C

31 October 22

Activities Update Qtr Ending September 2022 and Appendix 4C

×

Activities Update Qtr Ending September 2022 and Appendix 4C

31 May 22

Results of Annual General Meeting

×

Results of Annual General Meeting

31 March 23

OSX Completes Acquisition to Accelerate Revenue Growth

×

OSX Completes Acquisition to Accelerate Revenue Growth

31 March 23

Annual Report to Shareholders

×

Annual Report to Shareholders

31 March 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

31 March 23

Results of General Meeting

×

Results of General Meeting

31 March 22

Annual Report to shareholders

×

Annual Report to shareholders

31 March 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

31 July 23

Activities Update Qtr Ending June 2023 and Appendix 4C

×

Activities Update Qtr Ending June 2023 and Appendix 4C

31 July 23

Initial Director's Interest Notice - MK

×

Initial Director's Interest Notice - MK

31 January 23

Activities Update Qtr Ending December 2022 and Appendix 4C

×

Activities Update Qtr Ending December 2022 and Appendix 4C

31 August 23

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

31 August 22

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

30 November 23

Negotiation ongoing for InnoVentures Definitive JV Agreement

×

Negotiation ongoing for InnoVentures Definitive JV Agreement

30 May 23

Results of Annual General Meeting

×

Results of Annual General Meeting

30 March 23

Non-Renounceable Entitlement Offer Extension

×

Non-Renounceable Entitlement Offer Extension

30 March 23

Update - Proposed issue of securities - OSX

×

Update - Proposed issue of securities - OSX

29 June 23

Application for quotation of securities - OSX

×

Application for quotation of securities - OSX

29 December 21

Change to the Board of Directors

×

Change to the Board of Directors

29 December 21

Appendix 3X

×

Appendix 3X

29 August 23

Timeline extended for definitive agreements with CellHeal

×

Timeline extended for definitive agreements with CellHeal

29 April 22

Activities Update Qtr Ending March 2022 and Appendix 4C

×

Activities Update Qtr Ending March 2022 and Appendix 4C

29 April 22

Notice of Annual General Meeting

×

Notice of Annual General Meeting

29 April 21

Notice of Annual General Meeting

×

Notice of Annual General Meeting

28 September 22

More Osteopore Products Available on Prostheses List

×

More Osteopore Products Available on Prostheses List

28 September 22

Chile Government and University co-fund Osteopore research

×

Chile Government and University co-fund Osteopore research

28 May 21

Results of Annual General Meeting

×

Results of Annual General Meeting

OSX Fundamentals

Per Share Records

Historical data

Forecasted data

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.02 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.02 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 78.0 -69.4 -10.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.01 -0.03 -0.03 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.02 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.1 -97.5 -13.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.9 -15.2 -21.9 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.08 0.05 0.02 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.08 0.05 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 161.7 -40.3 -63.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 108 119 125 Lock Lock Lock
Basic m Lock Lock Lock Lock 108 119 125 Lock Lock Lock

Financial Records

Historical data

Forecasted data

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales AU$m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 265.5 -26.0 52.1 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 3 4 6 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 266.2 -25.7 119.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 52.5 52.7 75.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 48 47 24 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.8 -48.0 -10.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -164.7 -329.6 -238.7 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -3 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -52.1 -47.2 -9.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -175.8 -349.8 -251.6 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.3 -86.1 -15.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -129.3 -325.3 -247.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 8 0 1 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -17.0 -87.0 -1.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.4 -3.6 -2.4 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 9 5 1 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 10 6 4 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -9 -4 -1 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 1 2 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 9 5 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 9 5 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 200.3 -39.5 -61.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -19.0 -60.3 -117.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -21.6 -67.4 -204.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -40.6 -52.2 -112.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -32.5 -50.2 -111.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -29.3 -52.7 -106.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -140.8 -225.0 -198.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.5 1.2 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -95.3 -82.3 -61.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.8 9.6 2.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.7 9.2 1.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 92.7 83.6 43.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -140.4 -674.2 -269.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.3 2.9 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 8.2 3.0 1.7 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.2 1.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 21.6 25.1 54.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -129.3 -325.3 -247.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -19.0 -60.3 -117.7 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -19.0 -60.3 -117.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -21.6 -67.4 -204.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -21.6 -67.4 -204.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 44.6 122.3 215.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 109.6 125.0 136.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 154.2 247.3 351.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 116.3 191.3 450.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 38.0 55.9 -98.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OSX Shortsell

Frequently Asked Questions

The current share price of Osteopore Ltd. (OSX:ASX) is AU$0.05.
The 52-week high share price for Osteopore Ltd. (OSX:ASX) is AU$0.00.
The 52-week low share price for Osteopore Ltd. (OSX:ASX)? is AU$0.00.
Osteopore Ltd. (OSX:ASX) does not pay a dividend.
Osteopore Ltd. (OSX:ASX) does not pay a dividend.
Osteopore Ltd. (OSX:ASX) does not offer franking credits.
Osteopore Ltd. (OSX:ASX) is classified in the Healthcare.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.